Yin M - Search Results

1

LAPTM4B overexpression is a novel predictor of epithelial ovarian carcinoma metastasis.

Yin M, Xu Y, Lou G, Hou Y, Meng F, Zhang H, Li C, Zhou R. Yin M, et al. Int J Cancer. 2011 Aug 1;129(3):629-35. doi: 10.1002/ijc.25689. Epub 2010 Nov 28. Int J Cancer. 2011. PMID: 20857494

2

LAPTM4B-35 overexpression is an independent prognostic marker in endometrial carcinoma.

Meng FL, Yin MZ, Song HT, Yang H, Lou G, Zhou RL. Meng FL, et al. Int J Gynecol Cancer. 2010 Jul;20(5):745-50. doi: 10.1111/IGC.0b013e3181e02f90. Int J Gynecol Cancer. 2010. PMID: 20966643

3

Overexpression of LAPTM4B-35 in cervical carcinoma: a clinicopathologic study.

Meng F, Luo C, Hu Y, Yin M, Lin M, Lou G, Zhou R. Meng F, et al. Among authors: yin m. Int J Gynecol Pathol. 2010 Nov;29(6):587-93. doi: 10.1097/PGP.0b013e3181e0898e. Int J Gynecol Pathol. 2010. PMID: 20881850

4

The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.

Yin M, Zhao F, Lou G, Zhang H, Sun M, Li C, Hou Y, Li X, Meng F, Chen X. Yin M, et al. Int J Gynecol Cancer. 2011 Jan;21(1):92-9. doi: 10.1111/IGC.0b013e3181fe8b6e. Int J Gynecol Cancer. 2011. PMID: 21330834

5

Over-expression of LAPTM4B is associated with poor prognosis and chemotherapy resistance in stages III and IV epithelial ovarian cancer.

Yin M, Li C, Li X, Lou G, Miao B, Liu X, Meng F, Zhang H, Chen X, Sun M, Ling Q, Zhou R. Yin M, et al. J Surg Oncol. 2011 Jul 1;104(1):29-36. doi: 10.1002/jso.21912. Epub 2011 Mar 17. J Surg Oncol. 2011. PMID: 21416470

6

Correlation of LAPTM4B polymorphisms with cervical carcinoma.

Meng F, Song H, Luo C, Yin M, Xu Y, Liu H, Zhou R, Lou G. Meng F, et al. Among authors: yin m. Cancer. 2011 Jun 15;117(12):2652-8. doi: 10.1002/cncr.25833. Epub 2011 Jan 10. Cancer. 2011. PMID: 21656743 Free article.

7

LAPTM4B overexpression is a novel independent prognostic marker for metastatic ovarian tumors.

Yin M, Lou C, Zhang W, Meng F, Zhang H, Ning X, Zhou R, Dong X, Lou G. Yin M, et al. Int J Gynecol Cancer. 2012 Jan;22(1):54-62. doi: 10.1097/IGC.0b013e318234f9ac. Int J Gynecol Cancer. 2012. PMID: 22193644

8

MicroRNA-302b suppresses human epithelial ovarian cancer cell growth by targeting RUNX1.

Ge T, Yin M, Yang M, Liu T, Lou G. Ge T, et al. Among authors: yin m. Cell Physiol Biochem. 2014;34(6):2209-20. doi: 10.1159/000369664. Epub 2014 Dec 4. Cell Physiol Biochem. 2014. PMID: 25562167 Free article.

9

CLIC1 a novel biomarker of intraperitoneal metastasis in serous epithelial ovarian cancer.

Ye Y, Yin M, Huang B, Wang Y, Li X, Lou G. Ye Y, et al. Among authors: yin m. Tumour Biol. 2015 Jun;36(6):4175-9. doi: 10.1007/s13277-015-3052-8. Epub 2015 Jan 13. Tumour Biol. 2015. PMID: 25582317

10

Use of Plasma Metabolomics to Identify Diagnostic Biomarkers for Early Stage Epithelial Ovarian Cancer.

Fan L, Yin M, Ke C, Ge T, Zhang G, Zhang W, Zhou X, Lou G, Li K. Fan L, et al. Among authors: yin m. J Cancer. 2016 Jun 23;7(10):1265-72. doi: 10.7150/jca.15074. eCollection 2016. J Cancer. 2016. PMID: 27390602 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,997 results

Search Page

Filters